Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine use
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine use ; volume:16 ; number:1 ; day:1 ; month:6 ; year:2016 ; pages:1-11 ; date:12.2016
BMC infectious diseases ; 16, Heft 1 (1.6.2016), 1-11, 12.2016
- Creator
-
Duintjer Tebbens, Radboud J.
- Contributor
-
Hampton, Lee M.
Thompson, Kimberly M.
SpringerLink (Online service)
- DOI
-
10.1186/s12879-016-1537-8
- URN
-
urn:nbn:de:1111-2016060233819
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Duintjer Tebbens, Radboud J.
- Hampton, Lee M.
- Thompson, Kimberly M.
- SpringerLink (Online service)
Other Objects (12)
The differential impact of oral poliovirus vaccine formulation choices on serotype-specific population immunity to poliovirus transmission
Managing the risk of circulating vaccine-derived poliovirus during the endgame: oral poliovirus vaccine needs
Planning for globally coordinated cessation of bivalent oral poliovirus vaccine: risks of non-synchronous cessation and unauthorized oral poliovirus vaccine use
Immunogenicity evaluation of primary polio vaccination schedule with inactivated poliovirus vaccines and bivalent oral poliovirus vaccine
Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of potential non-synchronous cessation
Vaccine-related poliovirus shedding in trivalent polio vaccine and human immunodeficiency virus status: analysis from under five children
Rapid emergence and transmission of virulence-associated mutations in the oral poliovirus vaccine following vaccination campaigns
Health and economic consequences of different options for timing the coordinated global cessation of the three oral poliovirus vaccine serotypes
Circulating vaccine-derived poliovirus: a menace to the end game of polio eradication
Poliovirus excretion following vaccination with live poliovirus vaccine in patients with primary immunodeficiency disorders: clinicians’ perspectives in the endgame plan for polio eradication
Phänotypische und molekulargenetische Untersuchungen an Poliovirus Serotyp 1-Isolaten eines Poliovirus-Dauerausscheiders
A conserved glutathione binding site in poliovirus is a target for antivirals and vaccine stabilisation
The differential impact of oral poliovirus vaccine formulation choices on serotype-specific population immunity to poliovirus transmission
Managing the risk of circulating vaccine-derived poliovirus during the endgame: oral poliovirus vaccine needs
Planning for globally coordinated cessation of bivalent oral poliovirus vaccine: risks of non-synchronous cessation and unauthorized oral poliovirus vaccine use
Immunogenicity evaluation of primary polio vaccination schedule with inactivated poliovirus vaccines and bivalent oral poliovirus vaccine
Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of potential non-synchronous cessation
Vaccine-related poliovirus shedding in trivalent polio vaccine and human immunodeficiency virus status: analysis from under five children
Rapid emergence and transmission of virulence-associated mutations in the oral poliovirus vaccine following vaccination campaigns
Health and economic consequences of different options for timing the coordinated global cessation of the three oral poliovirus vaccine serotypes
Circulating vaccine-derived poliovirus: a menace to the end game of polio eradication
Poliovirus excretion following vaccination with live poliovirus vaccine in patients with primary immunodeficiency disorders: clinicians’ perspectives in the endgame plan for polio eradication
Phänotypische und molekulargenetische Untersuchungen an Poliovirus Serotyp 1-Isolaten eines Poliovirus-Dauerausscheiders
A conserved glutathione binding site in poliovirus is a target for antivirals and vaccine stabilisation
The differential impact of oral poliovirus vaccine formulation choices on serotype-specific population immunity to poliovirus transmission
Managing the risk of circulating vaccine-derived poliovirus during the endgame: oral poliovirus vaccine needs
Planning for globally coordinated cessation of bivalent oral poliovirus vaccine: risks of non-synchronous cessation and unauthorized oral poliovirus vaccine use
Immunogenicity evaluation of primary polio vaccination schedule with inactivated poliovirus vaccines and bivalent oral poliovirus vaccine
Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of potential non-synchronous cessation
Vaccine-related poliovirus shedding in trivalent polio vaccine and human immunodeficiency virus status: analysis from under five children
Rapid emergence and transmission of virulence-associated mutations in the oral poliovirus vaccine following vaccination campaigns
Health and economic consequences of different options for timing the coordinated global cessation of the three oral poliovirus vaccine serotypes
Circulating vaccine-derived poliovirus: a menace to the end game of polio eradication
Poliovirus excretion following vaccination with live poliovirus vaccine in patients with primary immunodeficiency disorders: clinicians’ perspectives in the endgame plan for polio eradication
Phänotypische und molekulargenetische Untersuchungen an Poliovirus Serotyp 1-Isolaten eines Poliovirus-Dauerausscheiders